🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
VXA-NVV-103 is a phase 1B Randomized, Double-Blind, Placebo-Controlled, Mul...
Status
Completed
Location
Rapid Medical Research
Start Date
2019-03-20
Trial ID
NCT03897309
Treatments Being Tested
Part 1: An open label, dose and age escalation phase to evaluate the safety...
Status
Terminated
Location
Ark Clinical Research
Start Date
2021-10-22
Trial ID
NCT05067933
Treatments Being Tested
This is a phase 1, single-center, placeb-controlled, double-blind study. Th...
Status
Completed
Location
CCST
Start Date
2015-10-20
Trial ID
NCT02547792
Treatments Being Tested
This study is designed to evaluate the safety and immunogenicity of two mon...
Status
Completed
Location
Ark Clinical Research
Start Date
2023-01-26
Trial ID
NCT05626803
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial...
Status
Completed
Location
Optimal Research
Start Date
2016-06-22
Trial ID
NCT02830932
Treatments Being Tested
A Phase 1b, multicenter, randomized, double-blind, placebo-controlled study...
Status
Completed
Location
WCCT
Start Date
2021-04-26
Trial ID
NCT04854746
Treatments Being Tested
This is a Phase 2b randomized, double-blind, placebo-controlled vaccination...
Status
Completed
Location
AltaSciences LA
Start Date
2021-12-27
Trial ID
NCT05212168
Treatments Being Tested
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial...
Status
Completed
Location
Celerion, Inc.
Start Date
2016-07-29
Trial ID
NCT02868073
A Phase 2 Randomized, Placebo- and Active-Controlled, Human Influenza A/Cal...
Status
Completed
Location
WCCT Global
Start Date
2016-08-31
Trial ID
NCT02918006
Treatments Being Tested
The purpose of this study was to demonstrate the safety and immunogenicity ...
Status
Completed
Location
WCCT
Start Date
2012-09
Trial ID
NCT01688297
Treatments Being Tested